Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Kidney C.O.P. Found To Be Five Times Stronger Than Chanca Piedra (known as Stone Breaker or Stone Crusher) at Reducing Calcium Oxalate Stone Growth (1)


News provided by

Calcium Oxalate Labs, Inc.

Apr 17, 2018, 10:07 ET

Share this article

Share toX

Share this article

Share toX

FORT LAUDERDALE, Fla., April 17, 2018 /PRNewswire/ -- Calcium Oxalate Labs, Inc. conducted in vitro tests comparing a single dose Kidney C.O.P. to a single dose of Chanca Pidra 5:1 Extract and Kidney C.O.P. was found to be five times stronger at inhibiting the rate of calcium oxalate crystal growth.1

99% Reduction In The Rate of Calcium Oxalate Crystal Stone Growth with Kidney C.O.P.2

Kidney C.O.P. "New 3-Pack" (90 Day Supply) Now Available When Ordering Through Amazon. - Customers Save 10%!
Kidney C.O.P. "New 3-Pack" (90 Day Supply) Now Available When Ordering Through Amazon. - Customers Save 10%!
Kidney C.O.P. Found To Be Five Times Stronger Than Chanca Piedra! (Chanca Piedra - Herbal Remedy Commonly Known as Stone Breaker)
Kidney C.O.P. Found To Be Five Times Stronger Than Chanca Piedra! (Chanca Piedra - Herbal Remedy Commonly Known as Stone Breaker)
Kidney C.O.P. has been added to Amazon's "Subscribe and Save" Autoship Program - Customers Save 5-15%!
Kidney C.O.P. has been added to Amazon's "Subscribe and Save" Autoship Program - Customers Save 5-15%!

Calcium Oxalate Labs, Inc., the maker of Kidney C.O.P. markets a new, patented dietary supplement for kidney health to the 20 million adults affected by calcium oxalate stones.3 The innovative Kidney C.O.P. formulation has been awarded four (4) U.S. Patents and has been optimized to inhibit the in vitro rate of calcium oxalate crystal stone growth by 99%.2 

Kidney C.O.P. New 3-Pack 90 Day Supply Is Now Available on Amazon – Save 10%

Kidney C.O.P. recently made available on Amazon a new convenient money saving 3-Pack 90 Day Supply. Customers can save an additional 10% purchasing this new convenient 3-Pack 90 day supply.

Kidney C.O.P. Is Now Offered In Amazon's Subscribe and Save Program - Save 5-15%

Kidney C.O.P. was recently added to "Amazon's Subscribe and Save Program" providing customers with the ability to save 5-15% off the already very affordable price. Customers can select to have a one month supply shipped every month or a 3 Pack 90 Day supply automatically shipped every three months.

Kidney C.O.P. also offers many additional benefits:

  • The active ingredients in Kidney C.O.P. have been shown in clinical studies to support the inhibition of calcium oxalate crystal stone growth.4
  • Kidney C.O.P contains ingredients that allow the product to be taken each and everyday compared to chanca piedra, which is limited to 3 months .4,5,6
  • Four (4) of the five (5) active ingredients in Kidney C.O.P. are FDA GRAS (Generally Recognized As Safe) and the fifth ingredient is MUSA (banana stems), a source of food utilized for centuries worldwide.5
  • Kidney C.O.P. is free from any Preservatives, Artificial Colors, Flavors, Sweeteners, Sugars, Soy, Gluten, Wheat, Yeast, Fish and Sodium
  • To ensure its long-term potency, Kidney C.O.P. has been tested under Zone IV stability, the toughest of FDA stability testing conditions.
  • Kidney C.O.P. has been developed, formulated, patented and is encapsulated in the United States.
  • Doctors are already utilizing Kidney C.O.P. themselves and recommending Kidney C.O.P.

For additional information, please visit KidneyCOP.com.

About the Company:

Calcium Oxalate Labs, Inc. is a privately-owned company. Further inquiries about the company or Kidney C.O.P. product can be directed through Customer Service at 1-800-586-9424 or "Contact Us' at KidneyCOP.com.

  1. https://kidneycop.com/wp-content/uploads/2018/03/Kidney-COP-vs-Chanca-Piedra-Calcium-Oxalate-Crystal-Growth-Testing-February-2018.pdf
  2. In vitro tests show that patented formula inhibits the rate of calcium oxalate crystal growth by 99%. Details can be found by reviewing patents 9,233,135 | 9,492,491 | 9,623,066 | and 9,789,152.
  3. https://www.ncbi.nlm.nih.gov/pubmed/22498635, http://eu-acme.org/europeanurology/upload_articles/Scales_July.pdf
  4. These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat cure or prevent any disease. Caution: If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before use. Discontinue use and consult your doctor if any adverse reactions occur.
  5. GRAS Designations: Citric Acid (21 CFR 184.1033), Magnesium Citrate  (21 CFR 184.1449), Inositol (IP6) (Phytin) (Phytic Acid)  (21 CFR 184.1370), Pyridoxine Hydrochloride (21 CFR 184.1676), Ingredient Five (Common Food Item) | Musa paradisiaca, banana stems.
  6. https://www.webmd.com/vitamins-supplements/ingredientmono-441-chanca%20piedra.aspx?activeingredientid=441, https://www.rxlist.com/chanca_piedra/supplements.htm#SafetyConcerns

CONTACT: Gregory Hayer, 215-353-2445, [email protected]

SOURCE Calcium Oxalate Labs, Inc.

Related Links

http://kidneycop.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.